Background: The pathogenesis of inflammatory bowel diseases (IBD) involves complex
interactions between the microbiome and the immune system. We evaluated the association …

Background & Aims Altering the intestinal microbiota has been proposed as a treatment for
inflammatory bowel diseases (IBDs), but there are no established associations between …

Inflammatory bowel disease (IBD) is a chronic, relapsing, inflammatory disorder which
comprises two main conditions: Crohn's disease (CD) and ulcerative colitis (UC). Although …

Current inflammatory bowel disease (IBD) treatments including non-biological, biological,
and nutritional therapies aim to achieve remission and mucosal healing. Treatment efficacy …

Background Intestinal bacteria produce metabolites and by‐products necessary for
homeostasis. Imbalance in this equilibrium is linked to multiple pathologies including …

Background Abnormalities have been described in the fecal microbiota of patients with IBD,
but it is not known whether they are specific for inflammatory bowel disease (IBD) or to some …

Background and Aims. Multiple studies have reported associations between inflammatory
bowel disease (IBD) and the flora disequilibrium of Bacteroides. We performed a meta …

Over the past recent years, a great number of studies have been directed toward the
evaluation of the human host–gut microbiota interaction, with the goal to progress the …

Inflammatory bowel diseases (IBD) are a group of chronic diseases of increasing worldwide
prevalence characterized by gastrointestinal (GI) inflammation leading to debilitating …

Two different conditions are included in inflammatory bowel disease (IBD), Crohn's disease
(CD) and ulcerative colitis (UC), being distinguished by chronic recurrence of gut …